Jordan S Shafran (Jordan Shafran)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Prostate Cancer

Transforming Growth Factor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science signaling

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan S Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela M Bynoe, Solanki Aniruddhsingh, Erica Markiewicz, Xiaobing Fan, Massimo Loda, Akash Patnaik
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan S Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela M Bynoe, Catherine Drovetsky, Solanki Aniruddhsingh, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan C Schürer, Alexander Swarbrick, David Brian Sykes, Akash Patnaik
Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Naser Jafari, Manohar Kolla, Tova Meshulam, Jordan S Shafran, Yuhan Qiu, Allison N Casey, Isabella R Pompa, Christina S Ennis, Carla S Mazzeo, Nabil Rabhi, Stephen R Farmer, Gerald V Denis
Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes. Science signaling 14 (710) (2021)
Jordan S Shafran, Naser Jafari, Allison N Casey, Balázs Győrffy, Gerald V Denis
BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer. Prostate cancer and prostatic diseases 24 (1) (2020)